Calidi Biotherapeutics, Inc. and its wholly owned subsidiary Redtail Biopharma, Inc.
- Form
- 8-K
- Filed
- Period
- Importance
- Routine
- Accession
- 0001493152-24-035939
- Document
- 8-K
- Exhibit 99.1
- Press release
- Makes a Regulation FD disclosure (7.01)
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2836) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.
- In8bio INAB public float $8M, Jun 30, 2025
- VivoSim Labs VIVS public float $8M, Sep 30, 2025
- Intensity Therapeutics INTS public float $7M, Jun 30, 2025
- Zeo ScientifiX ZEOX public float $7M, Apr 30, 2025, over 18 months old
- Abpro Holdings ABP public float $9M, Jun 30, 2025
